Birthmark Removal in CL
Birthmark Removal in CL section, includes general infrmation about Birthmark Removal Procedure, Birthmark Removal CL Local News, Birthmark Removal CL Surgeon Locator and other Birthmark Removal related material.
Birthmark Removal Procedure
Birthmarks are stains on your skin that appear at birth or shortly afterwards. Sometimes they are small and remain unnoticed, but sometimes they can be conspicuous and large. In the latter case you may feel uncomftable with your look and have a low self-esteem.
There are few kinds of bithmarks: Pigmented birthmarks also called congenital nevi or moles which may have some precancerous potential; Mongolian spots which are blue-green spots usually found in children and disappear as they grow older; and Coffee-cream spots which caused by to many pigment and usually pose only cosmetic problems. Macular stains, also called salmon patches, usually appear on babies and disappear later in life, except those found on the neck. Abnormal blood vessels create stains which are called Port wine stains. Those do not disappear during life and are especially concerning when appearing around the eyes. Hemangiomas are vascular tumors of many tiny blood vessels, which grow early in life around the head and neck. Many of them disappear after a few months but others may take years to disappear.
There are few methods by which a birthmark is removed. That depends largely on their size, type and location.
Laser therapy is one of the methods used, especially for superficial skin lesions. Laser energy targeted at a specific location causes the skin to fade and become lighter. In a case of port wine stain the laser makes it smaller and prevents from growing further. Laser treatments can be performed at any age, but sometimes several treatments are required.
Surgery is another method used for birthmarks, which cannot be removed by using laser. One example is hemangioma which is too large.
Laser treatment may take from several minutes to an hour, depending on the size of birthmarks. There is very little pain associated with the laser procedure. You may feel a mild burning sensation. Small children, or people sensitive to pain, may receive anesthetics. After the procedure has been completed, the skin is dark purple, and should improve after 7-10 days. Complete healing takes up to 6 weeks, during which you should avoid rubbing the place and exposing it to direct sun.
Every procedure has its risks. This one include pigmentation changes, resulting in areas of dark skin with bright patches. Such can be treated by additional laser treatments. Scar formation may also occur, where it can be treated by skin grafting. Other complications, such as bleeding or infection, are relatively rare.
Other Birthmark Removal Procedures
All Skin Procedures
Birthmark Removal CL (current)
CL Chemical Peel
CL Dermabrasion
CL Laser Hair Removal
CL Collagen Injections
More CL info...
Chile Bus The bus system is pretty sophisticated providing a great way to get from town to town. Take in mind that for the most part going from one city to the next will take longer than expected because they stop at many bus stations along the way. Some company's that travel all the country are Turbus and Pullman Bus. In Santiago, you can find both terminal's and more company on Universidad de Santiago subway station.
Chile General
Cocham?
Patagonia - especially the Torres del Paine National Park
Puc?n
San Pedro de Atacama
Plastic Surgery News...
- The British Dental Association welcomes Health Secretary Alan Johnson's announcement this week that £42 million would be made available for local fluoridation schemes where communities support the initiative.Susie Sanderson, Chair of the BDA's Executive Board, said:"Tooth decay is a significant problem in the UK.
- Data presented at the American Society of Clinical Oncology meeting suggest that 15% of patients who took sunitinib (Sutent®) developed heart failure. Researchers studied 48 patients with kidney cancer or gastrointestinal stromal tumor (GIST) on sunitinib and noted that 7 (15%) experienced heart failure. The problems began between 22 days and 435 days after beginning therapy, although most started within the first three months of treatment. Individuals with a history of heart failure, coronary artery disease or low BMI were at an even higher risk and 3 of 5 patients followed long term continued to have heart problems even after the drug was stopped. The researchers call for routine cardiac monitoring in patients receiving sunitinib and for cardiac adverse effects to be carefully examined in future trials of the drug. Previously, a retrospective analysis of phase I/II data published in the Lancet had noted the development of cardiovascular adverse events, including heart failure, in some patients with GIST who took the drug (see NeLM link). At the time of the Lancet paper, Pfizer released a statement agreeing that these cardiac risks do exist but added that they "were medically manageable in most patients and underscore the importance of having a collaborative team of health-care professionals working together to appropriately manage patients who have limited available options" in treating their cancer.